Status:
COMPLETED
Study Targeting Affect Regulation
Lead Sponsor:
University of California, San Francisco
Conditions:
HIV
AIDS
Eligibility:
MALE
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
This Phase Ib pilot RCT will examine the safety, feasibility, and acceptability of a multi-component intervention to address traumatic stress symptoms among HIV-positive, methamphetamine-using men who...
Detailed Description
In the multi-component intervention protocol, participants will complete expressive writing exercises where they will be asked to write about difficult life experiences. Following expressive writing, ...
Eligibility Criteria
Inclusion
- 18 years of age or older
- Speak English
- Self-identify as a man who has sex with men
- Have been diagnosed with HIV for at least 3 months
- Provide evidence of HIV-positive serostatus
- Report using methamphetamine during the past 30 days
Exclusion
- Do not have the capacity to provide informed consent
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2014
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT01237366
Start Date
September 1 2010
End Date
May 1 2014
Last Update
October 27 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCSF Center for AIDS Prevention Studies
San Francisco, California, United States, 94105